As technology continues to advance, the integration of artificial intelligence (AI) into GMP environments promises enhanced efficiency, productivity, and quality control. However, alongside these benefits come unique challenges and considerations, particularly concerning regulatory compliance.
The field of biomanufacturing is undergoing a remarkable transformation with the integration of Artificial Intelligence (AI) technologies. AI, a domain of computer science that aims to create machines capable of intelligent behavior, is revolutionizing the way biopharmaceuticals and other bioproducts are developed, manufactured, and refined.